All In Biotech

Drug Trial Radar · NCT00750880

An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.

International Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy.

Last checked: Nov 20, 2026Latest source record: Jul 22, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,681

Actual

Start

Sep 2008

Primary completion

Jul 2011

Study completion Jul 2011

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Sep 11, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This open-label, single arm study will investigate the safety, tolerability and efficacy of tocilizumab monotherapy, or combination therapy with non-biologic disease modifying antirheumatic drugs (DMARDs), in patients with severe active RA. Patients will receive tocilizumab 8mg/kg iv as a 60 minute infusion every 4 weeks for a total of 6 infusions. The anticipated time on study treatment is 3-12 months, and the target sample size is \>500 individuals.

Conditions

  • Rheumatoid Arthritis

Interventions

  • tocilizumab [RoActemra/Actemra]Drug

    8mg/kg iv (60 minute infusion)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Adverse Events (AEs): Overall SummaryTime frame: Weeks 4, 8, 12, 16, 20, and 24

Locations

282 sites in 25 countries. Site status is shown where the registry gives one.

  • Site not named

    Canberra, Australian Capital Territory, Australia

  • Site not named

    Coffs Harbour, New South Wales, Australia

  • Site not named

    Kogarah, New South Wales, Australia

  • Site not named

    Parramatta Park, New South Wales, Australia

  • Site not named

    Adelaide, South Australia, Australia

  • Site not named

    Fitzroy, Victoria, Australia

  • Site not named

    Geelong, Victoria, Australia

  • Site not named

    Melbourne, Victoria, Australia

  • Site not named

    Graz, Austria

  • Site not named

    Graz-Eggenberg, Austria

  • Site not named

    Innsbruck, Austria

  • Site not named

    Linz, Austria

  • Site not named

    Salzburg, Austria

  • Site not named

    Stockerau, Austria

  • Site not named

    Vienna, Austria

  • Site not named

    Vienna, Austria

  • Site not named

    Vienna, Austria

  • Site not named

    Aalst, Belgium

  • Site not named

    Brussels, Belgium

  • Site not named

    Brussels, Belgium

  • Site not named

    Brussels, Belgium

  • Site not named

    Brussels, Belgium

  • Site not named

    Edegem, Belgium

  • Site not named

    Ghent, Belgium

  • Site not named

    Hasselt, Belgium

  • Site not named

    Heusy, Belgium

  • Site not named

    Leuven, Belgium

  • Site not named

    Liège, Belgium

  • Site not named

    Merksem, Belgium

  • Site not named

    Montignies S/ Sambre, Belgium

  • Site not named

    Westmalle, Belgium

  • Site not named

    Edmonton, Alberta, Canada

  • Site not named

    Lethbridge, Alberta, Canada

  • Site not named

    Kelowna, British Columbia, Canada

  • Site not named

    Nanaimo, British Columbia, Canada

  • Site not named

    Vancouver, British Columbia, Canada

  • Site not named

    Vancouver, British Columbia, Canada

  • Site not named

    Quispamsis, New Brunswick, Canada

  • Site not named

    St. John's, Newfoundland and Labrador, Canada

  • Site not named

    Hamilton, Ontario, Canada

Showing 40 of 282 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.